Thursday December 14, 2017

HC seeks status report on dengue from Centre, Delhi govt

0
24

New Delhi:  Amid the rising cases of dengue in the national capital, the Delhi High Court on Thursday sought status report from the central and Delhi governments on the steps they have taken to control the mosquito-borne tropical disease.

A division bench of Chief Justice G. Rohini and Justice Jayant Nath said it was a serious issue and also impleaded civic agencies as parties in the case.

The court issued notice to the Centre, Delhi government, Municipal Corporations of Delhi (MCD) and New Delhi Municipal Council (NDMC) and sought their response by September 24.

“Issue notice to Centre, Delhi government. File status report explaining the steps already taken by them. File short affidavit within two weeks,” said the court.

Delhi government’s senior standing counsel Rahul Mehra told the court that “government is on pro-active mode” and has been taking adequate steps to treat dengue patients.

“We have taken many steps. We have added 1,000 beds and planning to increase more beds in private hospitals. We are concerned for the citizens,” Mehra told the bench.

The court was hearing a public interest litigation (PIL) filed by a law student Gauri Grover seeking registration of FIRs against directors of hospitals which denied treatment to a child who died of dengue and his parents later committed suicide.

However, the bench refrained from ordering lodging of an FIR and asked Grover’s counsel Satya Ranjan Swain to file additional documents relating to the negligence.

Dengue has claimed the lives of at least 16 people so far but the official toll is placed at five.

Delhi’s civic bodies have so far confirmed only five dengue deaths in the capital and the number of cases as 1,872.

With inputs from IANS

Next Story

Delhi records 3,829 cases of dengue, 502 of chikungunya till date

The year 2015 had reported the highest number of cases of dengue in the city, with the figure standing at 15,867 with 60 deaths.

0
27
cases of dengue
Dengue and Chikungunya are viral diseases transmitted to humans via infected mosquitoes. Pixabay

New Delhi, November 7, 2017 :  Delhi has so far recorded 3,829 cases of dengue and 502 cases of chikungunya, according to civic agencies on Monday.

While the national capital has witnessed a total of four dengue-related deaths till now, no deaths have been reported due to chikungunya.

ALSO READ You May Soon Be Able to Prevent Chikungunya With Vaccines! IIT-Roorkee Researchers Discover Drug to Fight the Disease

The year 2015 reported the highest number of cases of dengue in the city, with the figure standing at 15,867 with 60 deaths.

As for chikungunya, 2016 saw 7,117 cases — the highest in the last five years.

Civic agencies said that areas under the South Delhi Municipal Corporation reported the maximum cases of chikungunya and dengue this year.

ALSO READ What preventive steps have the city Government taken to control Dengue and Chikungunya, asks the Delhi High Court

Delhi has also reported a total of 552 malaria cases with no deaths so far. The figure is the second-highest after 2012 when the cases had soared to 822. (IANS)

Next Story

You May Soon Be Able to Prevent Chikungunya With Vaccines! IIT-Roorkee Researchers Discover Drug to Fight the Disease

At present, there are no immunizations or anti-viral medications available to cure Chikungunya, and the treatment is focused on mitigating the side effects related with the disease

0
65
cases of dengue
Dengue and Chikungunya are viral diseases transmitted to humans via infected mosquitoes. Pixabay

Roorkee, October 9, 2017 : Dengue and Chikungunya are known to strike fear in the country every year, so much so that the health graph of the city registers a steep rise in these cases. Both of the water-borne diseases, characterized by high fever and pain in the joints, take a toll on our lives. So far, there is no vaccine to immunize people against the spread of the Dengue and Chikungunya virus. However, researchers at IIT-Roorkee have now discovered that a commonly-utilized de-worming drug can be efficiently used for treatments against Chikungunya.

According to a report by PTI, Shailly Tomar, lead researcher and a professor at Indian Institute of Technology (IIT) Roorkee in Uttarakhand was quoted as saying, “Our research has shown that piperazine, a drug existing in the market, is successful in curbing the spread and replication of the Chikungunya virus in a lab setting.”

The drug, Piperazine, is usually used in de-worming treatments against round-words and pinworms. Using their expertise in virology and structure biology, experts have now discovered the anti-viral capabilities of the drug that can potentially prompt new therapies against the fatal, mosquito borne disease.

The researchers are currently testing the molecule on animals, and will consequently take it to clinical trials.

ALSO READ What preventive steps have the city Government taken to control Dengue and Chikungunya, asks the Delhi High Court

The molecular details uncovered in the study, which has been published in the journal Antiviral Research, will be additionally used to plan piperazine-derivative medications that are more compelling to fight against the Chikungunya virus.

Using X-ray crystallographic technique, in combination with computational science and fluorescence strategies, the researchers discovered that piperazine binds itself with the hydrophobic (water-hating) pocket of capsid protein present in the Chikungunya virus, which can reduce the spread of the virus.

“This pocket is key to the replication of the virus and its spread inside a host. Inhibiting the pocket prevents budding and spread of the virus and can help in treating the virus effectively using existing drugs,” Tomar said.

Chikungunya has become a major public health concern, with an increasing number of people being plagued by the disease every year.

 At present, there are no immunizations or anti-viral medications available to cure Chikungunya, and the treatment is focused on mitigating the side effects related with the disease. 

Developing a new anti-viral drug molecule can take up to 10 years. To tend to the disease on an immediate basis, Professor Tomar added, “We are looking at repositioning existing, approved drugs and testing these to see if they might inhibit or kill pathogenic viruses.”

 

 

Next Story

Delhi CM Arvind Kejriwal Rapped by Delhi High Court for Questioning Judge’s Decision

Arun Jaitley, represented by advocates Rajiv Nayar and Sandeep Sethi, filed a defamation suit against Kejriwal

0
34
Arvind Kejriwal
Arun Jaitley filed a defamation suit against Kejriwal and other AAP leaders. Wikimedia

August 26, 2017: Arvind Kejriwal, the Delhi Chief Minister, was rapped by the Delhi High Court today for questioning a judge’s decision to expedite defamation case filed by Finance Minister Arun Jaitley.

Also Read: Kapil Mishra Questions Arvind Kejriwal’s Absence in the Assembly Meet as Delhi CM skips Fourth Day in a row

Arun Jaitley accuses the AAP leaders of going against DDCA irregularities and disparaging Jaitley and his family on social media. Jaitley alleges that the AAP leaders have harmed his reputation and made defamatory statements.

The accused are Arvind Kejriwal, Kumar Vishwas, Sanjay Singh, Ashutosh, Raghav Chadha and Deepak Bajpai. The five AAP leaders had accused Jaitley of corruption charges as President of Delhi and District Cricket Association (DDCA).

Arun Jaitley, represented by advocates Rajiv Nayar and Sandeep Sethi, filed a defamation suit against Kejriwal.

On 26th July, the joint registrar was directed by the court to expedite the civil defamation suit.

Arvind Kejriwal’s advocate Anoop George Chaudhary was asked by the Judges why Arvind Kejriwal would file such a plea.

The bench comprising of Justice C Hari Shankar and Justice Gita Mittal explained that the high court was answerable to the Supreme Court about the delay of the case.


NewsGram is a Chicago-based non-profit media organization. We depend upon support from our readers to maintain our objective reporting. Show your support by Donating to NewsGram. Donations to NewsGram are tax-exempt.

Click here- www.newsgram.com/donate